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Introduction. Postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy operations still continue to be a
serious problem. Intravenous fluid administration has been shown to reduce PONV. Some patients have higher risk for PONV
described byAPFEL score. In this study, our aimwas to determine the effects of preoperative intravenous hydration onpostoperative
nausea and vomiting in high Apfel scored patients undergoing laparoscopic cholecystectomy surgery. Patients and Methods. This
study is performed with 50 female patients who had APFEL score 3-4 after ethics committee approval and informed consent was
taken from patients. The patients were divided into 2 groups: group 1 (P
1
): propofol + preoperative hydration and group 2 (P
2
):
propofol + no preoperative hydration. Results. When the total nausea VAS scores of groups P
1
and P
2
to which hydration was given
or not given were compared, a statistically significant difference was detected at 8th and 12th hours (𝑃 = 0.001 and 𝑃 = 0.041).
It was observed that in group P
1
, which was given hydration, the nausea VAS score was lower. When the total number of patients
who had nausea and vomiting in P
1
and P
2
, more patients suffered nausea in P
2
group. Discussion. Preoperative hydration may be
effective in high Apfel scored patients to prevent postoperative nausea.
1. Introduction
Postoperative nausea and vomiting (PONV) after laparo-
scopic cholecystectomy operations still continue to be a
serious problem. In the literature, the incidence of PONV is
reported to be around 10%. However, with the addition of
any one of the risk factors, the ratio may rise to proportions
that range between 21% and 79%. Intravenous fluid admin-
istration has been shown to reduce PONV. Some patients
have higher risk for PONV described by APFEL score. The
simplifiedApfel score includes four factors: female gender, no
smoking, postoperative use of opioids, and previous PONV
or motion-sickness in patients’ history that each one of these
risk factors were scored with 1 point and supposed to elevate
the PONV-incidence about 20%.
In order to prevent PONV, patient-controlled antiemesis,
oxygen administration, elimination of pain, and use of
antiemetic agents, such as sedatives, anxiolytics, antimus-
carinics, corticosteroids, antagonists of dopamine D2, sero-
tonin antagonists, and provision of adequate hydration, can
be applied. In the literature, there is different information
about the effectiveness of application of intravenous hydra-
tion on early and late nausea and vomiting.
In this study, our aim was to determine the effects of
preoperative intravenous hydration on postoperative nausea
and vomiting in patients undergoing laparoscopic cholecys-
tectomy surgery.
2. Patients and Method
Following the approval of local ethics committee, 50 women
who will undergo elective laparoscopic cholecystectomy with
ASA physical statuses I-II were included in the study. This
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study is performed with 50 female patients who had APFEL
score 3-4, after ethics committee approval and informed
consent was taken from patients. However, patients who have
body weight > 100 kg, who are older than 60 years old or
younger than 18 years of age, smokers, pregnant or lactating,
as well as patients who have cardiovascular, neurological,
pulmonary, or endocrine diseases, patients who are unable
to tolerate the process of the operation, patients who have
extreme anxiety immediately after the operation, patients
who have intraoperative excessive bleeding, patients who are
passed on to open surgery and patients who use antiemetic
drugs within 24 hours were all excluded from the study.
The patients were divided into 2 groups.
Group 1 (P
1
): propofol + preoperative hydration:
preoperative hydration: preoperative 1 hour, hydra-
tion with 15mL/kg Ringer’s lactate;
induction: propofol 2-3mL/kg + 1-2 g/kg fentanyl +
0.6–0.8mg/kg rocuronium;
intraoperative: 5mL/kg/h Ringer’s lactate;
Group 2 (P
2
): propofol + no preoperative hydration:
preoperative: preoperative 1 hour, basal fluid require-
ments were met with 2mL/kg Ringer’s lactate;
induction: propofol 2-3mL/kg + 1-2 g/kg fentanyl +
0.6–0.8mg/kg rocuronium;
intraoperative: 5mL/kg/h Ringer’s lactate.
Patients were received into the operation room without
premedication. ECG, oxygen saturation (SpO
2
), noninvasive
blood pressure, and end tidal carbon dioxide (ETCO
2
)
monitoring were performed. Ringer’s lactate infusion was
continued in all patients with 5mL/kg/h. Following adequate
preoxygenation, induction of anesthesia was performed in
the proper way. In maintenance of anesthesia, 50% air +
50% oxygen + 2–2.5 MAC sevoflurane were used. Patients’
heart rates, mean blood pressures, ETCO
2
(keeping the
range between 30 and 35mmHg) and SpO
2
values were
recorded 15min before and after induction. After removing
the gallbladder, while hemostasis was achieved analgesia was
achieved with im 75mg diclofenac sodium, in all groups.
After extubation, the hemodynamic followup of the patients
who were taken to the recovery unit was performed by a
physician who did not know the patient groups.The patients’
nausea, vomiting, and pain were examined by the same
physician at 0, 0.5, 1, 4, 8, 12, and 24th hours. As in a routine
practice, in patients with VAS value of 5 or more, 10mg
metoclopramide was administered slowly from intravenous
line. At the same intervals, their pain was assessed with VDS.
In case of VDS > 3, during the first 1 hour, 1mg/kg pethidine
HCL was injected intramuscularly. In patients who had been
taken to their rooms, an additional dose of diclofenac 75mg
was administered IM to those with VDS > 3.
3. Findings
There was no statistical difference between the demographic
characteristics of the patients.The statistical difference found
Table 1: Demographic values of the patients.
Group-I (P1)
(𝑛 = 25)
Group-II (P2)
(𝑛 = 25) 𝑃
Age (year)
(43 ± 11.9) (45 ± 10.2)
0.936[45 ± 20] [47 ± 20]
Max: 60 Min: 19 Max: 60 Min: 31
Weight (kg)
(71.28 ± 10.54) (72.16 ± 11.73)
0.907[69 ± 11.5] [72 ± 21.5]
Max: 93 Min: 55 Max: 95 Min: 55
BMI (Kg/m2)
(27.55 ± 4.03) (27.80 ± 3.83)
0.971[26.5 ± 3.45] [27.5 ± 6.55]
Max: 36.30,
Min: 20.70
Max: 34.9 Min:
20
Total hydration
(mL)
(1418 ± 244.4) (474 ± 103)
0.000∗
[1400 ± 200] [500 ± 150]
Max: 2000 Min:
950
Max: 700 Min:
200
Surgery duration
(min)
(39.12 ± 11.19) (34.44 ± 9.12)
0.049[38 ± 11.5] [32 ± 17.5]
Max: 61 Min: 23 Max: 50 Min: 21
Anaesthesia
duration (min)
(53.8 ± 10.67) (50.20 ± 10.07)
0.058[49 ± 20] [47 ± 20.5]
Max: 70 Min: 39 Max: 70 Min: 38
∗
𝑃 < 0.05 statistically significant.
between the total amounts of fluid given is due to the
preoperative hydration administered to group 1 and group
2. Groups did not differ when compared among themselves
(Table 1). Patients ASA values were found to be similar to the
previous stories of carsickness and PONV. Moreover, there
was no statistically significant difference between patients’
systolic and diastolic blood pressures during preoperative,
intraoperative, and postoperative periods.
In comparison of groups P
1
and P
2
, there was a decrease
in nausea VAS scores in the group that was given hydration
in the early period (0-1 hours) though it was not statistically
significant. In the late period (1–24 hours), at the 8th hour
and 12th hours, there was a significant difference in nausea
in terms of VAS values (𝑃 = 0.001, 𝑃 = 0.041). Even if
there was no significant difference in the subsequent hours, in
the propofol group to which hydration was given, VAS values
were found to be even lower (Table 2).
When the total nausea VAS scores of the groups to
which hydration was given or not given were compared, a
statistically significant difference was detected at 8th and 12th
hours (𝑃 = 0.001 and 𝑃 = 0.041). It was observed that in
group P
1
, which was given hydration, the nausea VAS score
was lower (Table 2).
When the total nausea and vomiting numbers of the
groups which were given or not given hydration were com-
pared, within the range of 1–24 hours, more nausea and
vomiting were observed in the group to which hydration was
not given (Table 3).
There was no significant difference between groups about
the metoclopramide use (Table 4).
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Table 2: Postoperative nausea VAS scores.
Zaman (saat) Group-I (P1)(𝑛 = 25)
Group-II (P2)
(𝑛 = 25) 𝑃
0 (0.32 ± 0.47) (0.72 ± 1.64) 0.849
[0-1] [0–6]
0.5 (0.52 ± 0.58) (0.56 ± 0.87) 0.707
[0–2] [0–3]
1 (0.8 ± 0.81) (0.64 ± 0.7) 0.414
[0–4] [0–3]
4 (1.2 ± 2.29) (2.12 ± 3.1) 0.323
[0–10] [0–10]
8 (0.12 ± 0.33) (0.96 ± 1.51) 0.001∗
[0-1] [0–7]
12 (0.12 ± 0.33) (0.32 ± 0.47) 0.041∗
[0-1] [0-1]
24 (0.08 ± 0.27) (0.28 ± 0.45) 0.068
[0-1] [0-1]
∗
𝑃 < 0.05 statistically significant.
Table 3: Dispersion of vomiting according to groups.
Post op
period (hour)
Group-I (P1)
(𝑛 = 25)
Group-II (P2)
(𝑛 = 25) 𝑃
0 — —
0.5 — —
1 — 1 (4%) 0.387
4 1 (4%) 2 (8%) 0.780
8 — — —
12 — — —
24 — — —
Total 1 (4%) 3 (12%) 4 patient
There was no significant difference between the groups in
terms of postoperative pain.
4. Discussion
In this study, the effects of preoperative i.v. hydration on
the incidence of postoperative nausea and vomiting are
examined. Nausea and vomiting have a complex etiology
which is affected by many factors such as age, gender, obesity,
previous history of PONV, carsickness history, smoking,
use of opioids during and after surgery, anesthesia and
surgical techniques, and postoperative pain [1–5]. Apfel
and coauthors stated that the most reliable independent
predictors of PONV were female gender, history of PONV
or motion sickness, nonsmoking, younger age, duration
of anaesthesia with volatile anaesthetics, and postoperative
opioids in their review [5]. As it was affected by so many
variables, we tried to ensure maximum standardization in
our study. In this way, demographic characteristics and the
characteristics related to the operation were found to be
similar in the groups. One of the important factors which
Table 4: Metoclopramide use in groups 1 and 2.
Post op period (hour) Group-I (P1)(𝑛 = 25)
Group-II (P2)
( 𝑛 = 25) 𝑃
0 — 2 (8%) 0.244
0.5 — — 0.564
1 — — 0.054
4 2 (8%) 5 (20%) 0.548
8 — 1 (4%) 0.286
12 — — 0.106
24 — — —
is observed after general anesthesia and which affects the
PONV is the surgical procedure. Since it is applicable in
daily life and provides other benefits laparoscopic surgery is
used routinely. Following laparoscopic surgery, PONV can
be seen very frequently [5–7]. After intraperitoneal CO
2
insufflation, increasing gradually abdominal pressure can
cause regurgitation. Furthermore, a nasogastric tube which is
inserted during laparoscopic surgery can also cause irritation
and thus increase the risk of PONV. Having been absorbed,
the insufflated CO
2
joins the systemic circulation and may
cause hypercarbia. The endogenous catecholamines which
increase as a result of hypercarbia may also increase the risk
of nausea and vomiting [8–11].
Several different drugs and techniques have been used
in the prevention and treatment of postoperative nausea and
vomiting. In our study, although no significant difference was
observed in the incidence of nausea in early stages (0-1 hr), in
the late period (1–24 hr) a significant difference was observed
at the 8th and 12th hours in the groups which were given
preoperative hydration. It was observed that hydration had to
decreased mild nausea (nausea VAS 2–4) by 27%, moderate
and higher nausea (nausea VAS > 5) by 36%. As for vomiting
rates in the groups, a significant difference observed only in
the first postoperative exit but not observed at other times,
and the incidence of vomiting in the hydrated group was
8%, while in the nonhydrated group it was 18%. When the
number of metoclopramide which was administered to two
groups was considered, a significant difference in the amount
ofmetoclopramide thatwas neededwas observed only during
the first 1 hour either following vomiting accompanied by
severe nausea (nausea VAS > 10) or vomiting with no nausea
at all. Subsequently, this significant difference disappeared
and 12% of the hydrated groups and 46% of the nonhydrated
groups needed metoclopropamide. When pain was analyzed
in each of the four groups, no significant difference was
observed in terms of VAS values, and finding moderate to
severe pain with VAS ≥ 3 to be 12% in the hydrated groups
and (20–24%) in the nonhydrated group aswell as observing a
reduction in pain close to 50% was evaluated as an important
clinical outcome.
In the literature, Fiddian-Green, who applied the liquids
prior to the induction of anesthesia, reported that in the early
postoperative period therewas no significant difference in the
incidence of nausea and in late period there was a decrease
in the postoperative nausea [12]. In the study carried out by
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Ali et al., it was stated that while the additional Hartmann
solution given to a group at 15mL/kg rate did not affect
the early PONV very much as compared to the group given
2mL/kg, it did prove effective in the late period [13]. On the
other hand, in the study done by Adanır et al., it was reported
that the groups which were given preoperative hydration
(12mL/kg HES or Ringer’s lactate) had lower VAS scores at
the postoperative 4th hour as compared to the control group
(2mL/kg); namely, through early hydration it was possible to
reduce the incidence of PONV [14]. In our study, as in the
previous studies, we also observed a significant decrease in
the incidence of PONV and drop in VAS scores in the 24
hours following anesthesia.
Pain that develops postoperatively is one of the factors
that increases the risk of PONV. In our study, no statistically
significant difference was found in terms of postoperative
analgesic use and postoperative pain. However, when the
moderate to severe pain (pain VAS ≥ 3) values were con-
sidered in all study groups, even though the pain level of
12% in the hydrated group and 20–24% in the nonhydrated
group may not to be considered as a statistically signifi-
cant difference, it was evaluated as an important clinical
outcome. While the study carried out by Chaudhary et al.
[15] reported that preoperative hydration caused a slight
decrease in postoperative pain scores and use of opioid, the
study conducted by Spencer [16] did not identify any such
relationship between hydration and postoperative pain.
That the additional fluid therapy reduces nausea mech-
anism still remains unknown. Perioperative hypoperfusion
of intestinal mucosa and the subsequent development of
possible ischemia may be one of the causes of PONV [17].
Hypovolemia that develops in the patients who are hungry
before the induction of anesthesia does not improve so easily
until postoperative period.
The additional fluid overload before the induction of
anesthesia most likely reduces the volume deficit and brings
the patients closer to normovolemia. In our study, we also
found that intravenous hydration given preoperatively could
reduce the incidence of PONV in relation to differences
in gender, type of surgery and technique in anesthesia.
Thus, we think that nausea and vomiting and the associated
complications can be decreased, and moreover it will be
possible to avoid the side effects that the use of antiemetics
brings about in the process of treatment.
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